IRDAI Approves Axis Bank's Capital Infusion into Max Life
IANS 07 February 2024
Insurance regulator, Insurance Regulatory and Development Authority of India (IRDAI) has approved the capital infusion by Axis Bank into Max Life, subject to the approval of the competition watchdog CCI. (competition commission of India).
 
The pension fund regulatory and development authority (PFRDA) has already approved the proposed change in shareholding pattern of Max Life pertaining to the infusion of capital by Axis Bank into Max Life. Accordingly, the capital infusion of Rs1,612 crore by Axis Bank into Max Life will be consummated on approval from the CCI, Max Financial Services said in a filing.
 
The company had made a disclosure earlier dated 9 August 2023 on capital infusion by Axis Bank into Max Life by the way of issuance of 14,25,79,161 equity shares of Max Life to Axis Bank for an aggregate investment of Rs1,612 crore which will help Max Life to support its future growth ambitions, to augment its capital position and to improve solvency margins.
 
The said proposal was approved by the company, subject to the receipt of all corporate and regulatory approvals including from IRDAI, PFRDA and CCI.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
Comments
mkgupta421961
7 months ago
No hurry to take decesion such type before poll of account holder to vote that they have any question doubt regard their money deposited with bank will be safe secure and grown up with this action
Array
Free Helpline
Legal Credit
Feedback